Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al.
Gerli
Roberto
R
Vaudo
Gaetano
G
Bocci
Elena Bartoloni
EB
Schillaci
Giuseppe
G
Bistoni
Onelia
O
Shoenfeld
Yehuda
Y
D000483:Alleles; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications* / Q000276:immunology; D050197:Atherosclerosis / Q000097:blood / Q000150:complications* / Q000276:immunology; D018106:CD28 Antigens / Q000032:analysis; D015704:CD4 Antigens / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism* / Q000473:pathology; D002340:Carotid Artery Diseases / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D008215:Lymphocytes, Null / Q000378:metabolism* / Q000473:pathology; D010456:Peptides, Cyclic / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism
D018106:CD28 Antigens; D015704:CD4 Antigens; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide